Citation Impact
Citing Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
2018 Standout
Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli
2007
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Genetic Structures at the Origin of Acquisition of the β-Lactamase bla KPC Gene
2008
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes
2017
Nucleic acid detection with CRISPR-Cas13a/C2c2
2017 StandoutScience
Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes
2008
Genetic Factors Associated with Elevated Carbapenem Resistance in KPC-Producing Klebsiella pneumoniae
2010
Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258
2009
First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States
2008
First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase
2007
Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing bla KPC in the United States
2008
Genomic Analysis of Hospital Plumbing Reveals Diverse Reservoir of Bacterial Plasmids Conferring Carbapenem Resistance
2018
Simple Disk-Based Method for Detection of Klebsiella pneumoniae Carbapenemase-Type β-Lactamase by Use of a Boronic Acid Compound
2008
Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae
2007
Occurrence of OXA-58-Like Carbapenemases in Acinetobacter spp. Collected over 10 Years in Three Continents
2006
Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
1997
Development of a Multilocus Sequence Typing Scheme for Characterization of Clinical Isolates of Acinetobacter baumannii
2005
Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing
2006
Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faecium
1996
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Identification of Carbapenem-Resistant Klebsiella pneumoniae Harboring KPC Enzymes in New Jersey
2007
Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000–2004)
2006
Disinfection of Hospital Rooms Contaminated With Vancomycin-Resistant Entemcocms faecium
1998
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
2017
Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae
2015
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999–2005)
2006
Antimicrobial Consumption Data From Pharmacy and Nursing Records: How Good Are They?
2005
VEB-1 Extended-Spectrum β-lactamase–producing Acinetobacter baumannii, France1
2006
Vancomycin-Resistant Enterococci
2000
Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut
2013
Current status of carbapenemases in Latin America
2013
Surveillance for antimicrobial resistance among clinical isolates of Gram-negative bacteria from intensive care unit patients in China, 1996 to 2002
2005
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <em>Enterobacteriaceae</em>
2018
Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004
2005
Evaluation of prevalence and risk factors for methicillin-resistant Staphylococcus aureus colonization in veterinary personnel attending an international equine veterinary conference
2007
A Pilot Study of Antibiotic Cycling in the Community Hospital Setting
2005
Use of Active Surveillance Cultures to Detect Asymptomatic Colonization With Carbapenem-Resistant Klebsiella pneumoniae in Intensive Care Unit Patients
2008
Vancomycin-Resistant Enterococci among Chronic Hemodialysis Patients: A Prospective Study of Acquisition
2001
Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006)
2007
Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection
1993
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
2007
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in Therapy
2017
Resistance in gram-negative bacteria: Enterobacteriaceae
2006
Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina
2005
A Hospitalwide Intervention Program to Optimize the Quality of Antibiotic Use: Impact on Prescribing Practice, Antibiotic Consumption, Cost Savings, and Bacterial Resistance
2003
What's new in antibiotic resistance? Focus on beta-lactamases
2006
In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp.
2006
Extended-spectrum β-lactamases in North America, 1987–2006
2008
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program
2004
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
2006
Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B
2005
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals
2003
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
2005
Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II
2006
Successful Treatment with Ampicillin and Fluoroquinolones of Human Endocarditis due to High-Level Gentamicin-Resistant Enterococci
1998
Activities of various β-lactams and β-lactam/β-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains
2005
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
2006
Efflux pumps expression and its association with porin down-regulation and β-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil
2010
Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit
2006
The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species
2006
Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis
2003
Evaluation of an Intervention Designed to Decrease the Rate of Nosocomial Methicillin-ResistantStaphylococcus aureusInfection by Encouraging Decreased Fluoroquinolone Use
2006
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Vancomycin-Resistant Enterococci Outside the Health-Care Setting: Prevalence, Sources, and Public Health Implications
1997
Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel
2007
Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase–Producing Enterobacteriaceae: A Multihospital Study
2012
The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units
2001
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination
2010
Completely Resistant Acinetobacter baumannii Strains
2002
Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years
2003
Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐ResistantStaphylococcus aureus
2008
Changes in the Prevalence of Vancomycin‐Resistant Enterococci in Response to Antimicrobial Formulary Interventions: Impact of Progressive Restrictions on Use of Vancomycin and Third‐Generation Cephalosporins
2003
The continuing challenge of ESBLs
2007
IRT and CMT β-lactamases and inhibitor resistance
2008
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
2007
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
2006
Emergence of Carbapenem Resistance inAcinetobacter baumanniiRecovered From Blood Cultures in Australia
2006
Post-Neurosurgical Meningitis Due to Multidrug-ResistantAcinetobacter baumaniiTreated with Intrathecal Colistin: Case Report and Review of the Literature
2006
New information about the polymyxin/colistin class of antibiotics
2009
Reducing Vancomycin Use Utilizing a Computer Guideline: Results of a Randomized Controlled Trial
1998
Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials
2002
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome
2002
A Nosocomial Outbreak of Community‐Associated Methicillin‐Resistant Staphylococcus aureus among Healthy Newborns and Postpartum Mothers
2006
Effectiveness of a Vancomycin Restriction Policy in Changing the Prescribing Patterns of House Staff
2000
Infection Control — A Problem for Patient Safety
2003 Standout
An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
2009
Electronic antibiotic stewardship--reduced consumption of broad-spectrum antibiotics using a computerized antimicrobial approval system in a hospital setting
2008
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
2008 Standout
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system
2009
Infection Control in the ICU
2001
SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state
2010
Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings
2005
Abdominal Tuberculosis in Patients Infected with the Human Immunodeficiency Virus
1995
A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005
2008
Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing
2003
Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns
2009
What is in the pipeline for Gram-negative pathogens?
2008
Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008
2010
Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial
2007
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Occurrence of plasmidic AmpC type β-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004)
2006
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
2005 Standout
Impact of Limited Cephalosporin Use on Prevalence of Methicillin-ResistantStaphylococcus aureusin the Intensive Care Unit
2009
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
2017
Role of the Microbiota in Immunity and Inflammation
2014 Standout
A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England
2004
Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom
2009
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
The Science of Antibiotic Discovery
2020 Standout
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study
2007
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
2012
Infection with PanresistantKlebsiella pneumoniae:A Report of 2 Cases and a Brief Review of the Literature
2009
Prevalence of MRSA colonization in peripartum mothers and their newborn infants
2008
Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance
2008
Control of an Outbreak of Pandrug-Resistant Acinetobacter baumannii Colonization and Infection in a Neonatal Intensive Care Unit
2007
Treatment Options for Vancomycin- Resistant Enterococcal Infections
2002
Global Burden of Tuberculosis
1999 Standout
Outbreak by Ventilator-Associated ST11 K. pneumoniae with Co-production of CTX-M-24 and KPC-2 in a SICU of a Tertiary Teaching Hospital in Central China
2016
Emergence of Community-Associated Methicillin-ResistantStaphylococcus aureusInfection Among Patients With End-Stage Renal Disease
2006
Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options
2008
Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat
2019
Emergence and management of drug-resistant enterococcal infections
2008
OXA-type carbapenemases
2006
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme
2008
Resistance in Gram-Negative Bacteria: Enterobacteriaceae
2006
Novel Antibiotic Combinations against Infections with Almost Completely Resistant Pseudomonas aeruginosa and Acinetobacter Species
2006
Hospital-Based Strategies for Combating Resistance
2006
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
2008
Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
1996
Carbapenem‐ResistantEscherichia coliHarboringKlebsiella pneumoniaeCarbapenemase β‐Lactamases Associated with Long‐Term Care Facilities
2008
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Class A carbapenemases
2007
Microbial biosurfactants production, applications and future potential
2010 Standout
Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia
2005
Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit
2001
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Dissemination of Community-Associated Methicillin-Resistant Staphylococcus aureus in a Tertiary Care Hospital
2008
Acinetobacter Infection
2008
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Effective Treatment of Multidrug-Resistant Enterococcal Experimental Endocarditis with Combinations of Cell Wall-Active Agents
1996
Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline
2006
Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital
2009
Carbapenem-Resistant Enterobacteriaceae Infections in Children
2015
Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes
2007
Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus among newly arrested men in Baltimore, Maryland
2008
Antimicrobial management measures to limit resistance: A process-based conceptual framework
2001
Spread of methicillin‐resistant Staphylococcus aureus USA300 in a neonatal intensive care unit
2008
VEB-1 Extended-Spectrum β-lactamase–producingAcinetobacter baumannii, France
2006
An Outbreak of Multidrug-Resistant <EMPH TYPE="ITAL">Acinetobacter baumannii</EMPH> Associated With Pulsatile Lavage Wound Treatment
2004
Risk Factors for Neonatal Methicillin-ResistantStaphylococcus aureusInfection in a Well-Infant Nursery
2007
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
2006
Pediatric Carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a High-prevalence Region in the United States
2014
Effect of the Increasing Use of Piperacillin/Tazobactam on the Incidence of Vancomycin-Resistant Enterococci in Four Academic Medical Centers
2004
Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii
2006
Successful Treatment of Persistent Bacteremia due to Vancomycin-Resistant, Ampicillin-Resistant Enterococcus faecium
1995
Repetitive-DNA-element PCR fingerprinting and antibiotic resistance of pan-European multi-resistant Acinetobacter baumannii clone III strains
2005
Successful Eradication of a Monoclonal Strain ofKlebsiella pneumoniaeduring aK. pneumoniaeCarbapenemase-ProducingK. pneumoniaeOutbreak in a Surgical Intensive Care Unit in Miami, Florida
2010
Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: Association with antibiotic usage
1998
Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future
2018
Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge
2006
Proliferation and significance of clinically relevant β‐lactamases
2013
Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment
2003
Effectiveness of Pharmacy Policies Designed to Limit Inappropriate Vancomycin Use: A Population-Based Assessment
2002
In vitro activity of the -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
2009
Identification and Evolution of Drug Efflux Pump in Clinical Enterobacter aerogenes Strains Isolated in 1995 and 2003
2008
Spread of efflux pump-overexpressing, non-metallo-β-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity
2005
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)
2004
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii
2007
“Stormy waters ahead”: global emergence of carbapenemases
2013
Has the era of untreatable infections arrived?
2009
Prevalence and antimicrobial patterns of Acinetobacter baumannii on hands and nares of hospital personnel and patients: The iceberg phenomenon again
2002
Active promotion of antibiotic guidelines: an intensive program
2003
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
2010
Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria
2008
Emergence of imipenem resistance in clinical Escherichia coli during therapy
2008
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
2009
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin–tazobactam
2008
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
2006
Investigation of a nosocomial outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting
2005
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections
2004
Successful Control of an Outbreak ofKlebsiella pneumoniaeCarbapenemase—ProducingK. pneumoniaeat a Long-Term Acute Care Hospital
2010
Tigecycline for Treatment of Pneumonia and Empyema Caused by Carbapenemase‐Producing Klebsiella pneumoniae
2007
A Potential Decline in Life Expectancy in the United States in the 21st Century
2005 Standout
Antibiotic susceptibility and mechanisms of β-lactam resistance among clinical strains of Pseudomonas aeruginosa: First report in Algeria
2008
Predictors and Outcomes for Pregnant Women with Vaginal-Rectal Carriage of Community-Associated Methicillin-Resistant Staphylococcus aureus
2007
A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis
2002
Aminoglycosides: An Overview
2016
Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999–2001
2006
Control of an Outbreak of Multidrug-ResistantAcinetobacter baumannii-calcoaceticusColonization and Infection in an Intensive Care Unit (ICU) Without Closing the ICU or Placing Patients in Isolation
2006
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
2007
Efflux-Mediated Drug Resistance in Bacteria
2009
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
2012 Standout
A Randomized Double‐Blind Study of Caspofungin versus Amphotericin for the Treatment of Candidal Esophagitis
2001
Efflux pumps as antimicrobial resistance mechanisms
2007
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
2004
Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae
2011
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)
2006
The Role of "Colonization Pressure" in the Spread of Vancomycin-Resistant Enterococci
1998
Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Infection
2010
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
2006
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007–2009 SENTRY Antimicrobial Surveillance Program
2013
Early Experience with Tigecycline for Ventilator‐Associated Pneumonia and Bacteremia Caused by Multidrug‐Resistant Acinetobacter baumannii
2007
The Spread ofKlebsiella pneumoniaeCarbapenemase–ProducingK. pneumoniaeto Upstate New York
2006
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001–2004)
2006
Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections
2009
Nosocomial Outbreak of Infection With Pan–Drug-ResistantAcinetobacter baumanniiin a Tertiary Care University Hospital
2009
Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP
2003
Staphylococcus aureusBloodstream Infections: Risk Factors, Outcomes, and the Influence of Methicillin Resistance in Calgary, Canada, 2000–2006
2008
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
2009 Standout
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome
2006
Herpes Zoster
2013 Standout
Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital
2006
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Interplay between β-lactamases and new β-lactamase inhibitors
2019
Antimicrobial use and bacterial resistance
2000
Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumannii
2003
Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial
2007
Dissemination of IMP-1 Metallo-β-Lactamase–Producing Acinetobacter Species in a Brazilian Teaching Hospital
2006
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases
2008
Relationship between Spread of Methicillin‐ResistantStaphylococcus aureusand Antimicrobial Use in a French University Hospital
2003
Methicillin-resistant Staphylococcus aureus carriage, infection and transmission in dialysis patients, healthcare workers and their family members
2007
Advanced and controlled drug delivery systems in clinical disease management
1996
Gram-negative antibiotic resistance: there is a price to pay
2008
Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
2003
Interhospital transfer of pan-resistant Acinetobacter strains in Johannesburg, South Africa
2004
High-Density Livestock Operations, Crop Field Application of Manure, and Risk of Community-Associated Methicillin-ResistantStaphylococcus aureusInfection in Pennsylvania
2013
Efflux-mediated antimicrobial resistance
2005
How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies
2010
Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention
2011
Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis
1997
Multi-resistant gram-negative organisms in Maryland: A statewide survey of resistant Acinetobacter baumannii
2005
Persistent Acinetobacter baumannii? Look Inside Your Medical Equipment
2004
Empirical Antibiotic Choice for the Seriously Ill Patient: Are Minimization of Selection of Resistant Organisms and Maximization of Individual Outcome Mutually Exclusive?
2003
“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy
2004
Invasive Methicillin-Resistant <EMPH TYPE="ITAL">Staphylococcus aureus</EMPH> Infections in the United States
2007 Standout
Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis
2002 Standout
Management of multidrug-resistant organisms in health care settings, 2006
2007
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage
1999
Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells
2005
KEGG as a reference resource for gene and protein annotation
2015 Standout
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)
2009
Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit
2006
Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period
2003
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals
2010
Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae
2016
Management of Community‐Associated Methicillin‐Resistant Staphylococcus aureus Infections in Children
2006
The New β-Lactamases
2005
Do we really need new anti-infective drugs?
2003
Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa
2007
Ventilator-associated Pneumonia
2002 Standout
Evaluation of CHROMagar KPC for Rapid Detection of Carbapenem-Resistant Enterobacteriaceae
2008
Genes Encoding TEM-4, SHV-2, and CTX-M-10 Extended-Spectrum β-Lactamases Are Carried by MultipleKlebsiella pneumoniaeClones in a Single Hospital (Madrid, 1989 to 2000)
2002
Plazomicin: A Next‐Generation Aminoglycoside
2018
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae : Risk Factors, Molecular Epidemiology, and Clinical Outcome
2006
Rapid Detection of bla KPC Carbapenemase Genes by Real-Time PCR
2008
Role ofampDHomologs in Overproduction of AmpC in Clinical Isolates ofPseudomonas aeruginosa
2008
Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
2013
Genetic Linkage and Cotransfer of a Novel, vanB -Containing Transposon (Tn 5382 ) and a Low-Affinity Penicillin-Binding Protein 5 Gene in a Clinical Vancomycin-Resistant Enterococcus faecium Isolate
1998
Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo
2019
High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression
2008
Multidrug-ResistantAcinetobacter baumannii
2005
Optimal Surveillance Culture Sites for Detection of Methicillin-Resistant Staphylococcus aureus in Newborns
2006
Relevance of resistance levels to carbapenems and integron-borne bla IMP-1, bla IMP-7, bla IMP-10 and bla VIM-2 in clinical isolates of Pseudomonas aeruginosa
2009
Tridecaptin M, a New Variant Discovered in Mud Bacterium, Shows Activity against Colistin- and Extremely Drug-Resistant Enterobacteriaceae
2019
Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center
2004
Antibiotic resistance is ancient
2011 StandoutNature
Updated Functional Classification of β-Lactamases
2009 Standout
Carbapenemases: the Versatile β-Lactamases
2007 Standout
Impact of a web‐based antimicrobial approval system on broad‐spectrum cephalosporin use at a teaching hospital
2003
In Vitro Activities of the β-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with β-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains
2004
Reliability of the E-Test Method for Detection of Colistin Resistance in Clinical Isolates of Acinetobacter baumannii
2005
Genomewide Identification of Genetic Determinants of Antimicrobial Drug Resistance inPseudomonas aeruginosa
2009
Multicenter Studies of Tigecycline Disk Diffusion Susceptibility Results for Acinetobacter spp
2006
Polymeric Systems for Controlled Drug Release
1999 Standout
Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management
2014
Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4
2008
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
2012
Temporal flux in β-lactam resistance among Klebsiella pneumoniae in Western Australia
2016
Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacter baumannii
2005
Identification of an OprD Homologue in Acinetobacter baumannii
2005
Comparative In Vitro Activities of Daptomycin and Vancomycin against Resistant Gram-Positive Pathogens
2000
Detection of vancomycin-resistant enterococci in fecal samples by PCR
1997
Plasmid-Mediated qnrB2 and Carbapenemase Gene bla KPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates
2008
AmpC β-Lactamases
2009 Standout
Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors
2018
Distribution of Intrinsic Plasmid Replicase Genes and Their Association with Carbapenem-Hydrolyzing Class D β-Lactamase Genes in European Clinical Isolates of Acinetobacter baumannii
2011
Development and Evaluation of a Real-Time PCR Assay for Detection of Klebsiella pneumoniae Carbapenemase Genes
2008
First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America
2006
Vital signs: carbapenem-resistant Enterobacteriaceae.
2013
Multidrug-ResistantAcinetobacterExtremity Infections in Soldiers
2005
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel
2006
Sampling the Antibiotic Resistome
2006 StandoutScience
Methicillin-resistant Staphylococcus aureus infections among healthy full-term newborns
2007
Antimicrobial Activities of Tigecycline and Other Broad-Spectrum Antimicrobials Tested against Serine Carbapenemase- and Metallo-β-Lactamase-Producing Enterobacteriaceae : Report from the SENTRY Antimicrobial Surveillance Program
2007
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals
2007
Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
2018
Community-Acquired Staphylococcus aureus Infections in Term and Near-Term Previously Healthy Neonates
2006
Effect of MexXY Overexpression on Ceftobiprole Susceptibility in Pseudomonas aeruginosa
2009
Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases,
2007
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
2014
Multidrug-resistantAcinetobacterInfection Mortality Rate and Length of Hospitalization
2007
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Methicillin-Resistant Staphylococcus aureus at Canoe Camp
2006
Differences in Clinical and Molecular Characteristics of Skin and Soft Tissue Methicillin-Resistant Staphylococcus aureus Isolates between Two Hospitals in Northern California
2007
Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
2018
Prevalence of Newer β-Lactamases in Gram-Negative Clinical Isolates Collected in the United States from 2001 to 2002
2006
Systematic Review of Antimicrobial Drug Prescribing in Hospitals
2006
First Report of the Emergence of CTX-M-Type Extended-Spectrum β-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System
2007
Deep Eutectic Solvents: A Review of Fundamentals and Applications
2020 Standout
Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa.
2007
The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida
2002
Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals
2004
Three Decades of β-Lactamase Inhibitors
2010 Standout
Antimicrobial Susceptibility among Pathogens Collected from Hospitalized Patients in the United States and In Vitro Activity of Tigecycline, a New Glycylcycline Antimicrobial
2006
Differential Selection of Single-Step AmpC or Efflux Mutants of Pseudomonas aeruginosa by Using Cefepime, Ceftazidime, or Ceftobiprole
2010
Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001
2003
Identification of Acinetobacter baumannii by Detection of the bla OXA-51-like Carbapenemase Gene Intrinsic to This Species
2006
Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa
2009
Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1
2021 StandoutNobel
Results of an antimicrobial control program at a university hospital
2005
The Synthetic N-Terminal Peptide of Human Lactoferrin, hLF(1-11), Is Highly Effective against Experimental Infection Caused by Multidrug-Resistant Acinetobacter baumannii
2004
bla VIM-2 and bla VIM-7 Carbapenemase-Producing Pseudomonas aeruginosa Isolates Detected in a Tertiary Care Medical Center in the United States: Report from the MYSTIC Program
2006
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Emergence of Serratia marcescens , Klebsiella pneumoniae , and Escherichia coli Isolates Possessing the Plasmid-Mediated Carbapenem-Hydrolyzing β-Lactamase KPC-2 in Intensive Care Units of a Chinese Hospital
2008
In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci
1995
Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A β-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France
2008
Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii : Molecular Basis for the Differential Mechanisms of Action
2006
Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases
2003
Endemic Carbapenem Resistance Associated with OXA-40 Carbapenemase among Acinetobacter baumannii Isolates from a Hospital in Northern Spain
2002
Susceptibility of the Acinetobacter calcoaceticus–A. baumannii complex to imipenem, meropenem, sulbactam and colistin
2004
Choline and Geranate Deep Eutectic Solvent as a Broad‐Spectrum Antiseptic Agent for Preventive and Therapeutic Applications
2016
Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality
2007
Polymyxin B and Doxycycline Use in Patients with Multidrug-Resistant Acinetobacter baumannii Infections in the Intensive Care Unit
2006
Vancomycin-Resistant Enterococci
2000
The role of new β-lactamase inhibitors in gram-negative infections
2019
Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK
2002
Molecular Epidemiology of Sequential Outbreaks of Acinetobacter baumannii in an Intensive Care Unit Shows the Emergence of Carbapenem Resistance
2004
Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase
2009
Channel Formation by CarO, the Carbapenem Resistance-Associated Outer Membrane Protein of Acinetobacter baumannii
2005
Methicillin-resistant Staphylococcus aureus: risk factors associated with community-onset infections in Denmark
2008
In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii
2004
OXA-58, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems inAcinetobacter baumannii
2004
Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
2009
Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
2014
Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa
2005
Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D
2007
Randomized, Double-Blind, Multicenter Study of Caspofungin versus Amphotericin B for Treatment of Oropharyngeal and Esophageal Candidiases
2002
Presence of the KPC Carbapenemase Gene in Enterobacteriaceae Causing Bacteremia and Its Correlation with In Vitro Carbapenem Susceptibility
2008
Establishment of In Vitro Susceptibility Testing Methodologies and Comparative Activities of Piperacillin in Combination with the Penem β-Lactamase Inhibitor BLI-489
2008
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
2015
Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital
2007
Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilis
2008
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Surveillance of Community-Based Reservoirs Reveals the Presence of CTX-M, Imported AmpC, and OXA-30 β-Lactamases in Urine Isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. Community
2008
Replacement of Broad-Spectrum Cephalosporins by Piperacillin-Tazobactam: Impact on Sustained High Rates of Bacterial Resistance
2004
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing
2016
Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens
2019
Functional Characterization of Tn 4401 , a Tn 3 -Based Transposon Involved in bla KPC Gene Mobilization
2011
Molecular mechanisms of β-lactam resistance in carbapenemase-producing Klebsiella pneumoniae from Sri Lanka
2014
Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid
2008
Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
2006
Carbapenemases: Molecular Diversity and Clinical Consequences
2007
Kinetics Study of KPC-3, a Plasmid-Encoded Class A Carbapenem-Hydrolyzing β-Lactamase
2005
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy
2007
Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA
2015
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
2008
Plant and Animal Sensors of Conserved Microbial Signatures
2010 StandoutScienceNobel
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Enterobacter spp.: Update on Taxonomy, Clinical Aspects, and Emerging Antimicrobial Resistance
2019
Occurrence and Phenotypic Characteristics of Extended-Spectrum β-Lactamases among Members of the Family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and Evaluation of Diagnostic Tests
2003
Antimicrobial Stewardship Programs in Health Care Systems
2005
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
2009
Routine Cycling of Antimicrobial Agents as an Infection-Control Measure
2003
Community-Acquired MRSA Infections in North Carolina Children: Prevalence, Antibiotic Sensitivities, and Risk Factors
2009
Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic Resistance
2012
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
2009
High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of bla ACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE
2006
VIM-1 Metallo-β-lactamase inAcinetobacter baumannii
2006
Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 β-Lactamases
2009
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Efflux Pumps, OprD Porin, AmpC β-Lactamase, and Multiresistance in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients
2010
Inhibition of Class A β-Lactamases by Carbapenems: Crystallographic Observation of Two Conformations of Meropenem in SHV-1
2008
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii
2002
Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study
2011
Works of John Quale being referenced
Molecular Epidemiology of a Citywide Outbreak of Extended‐Spectrum β‐Lactamase–Producing Klebsiella pneumoniae Infection
2002
A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City
2006
Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B
2005
MRSA Causing Infections in Hospitals in Greater Metropolitan New York: Major Shift in the Dominant Clonal Type between 1996 and 2014
2016
Manipulation of a Hospital Antimicrobial Formulary to Control an Outbreak of Vancomycin-Resistant Enterococci
1996
Ampicillin plus ciprofloxacin therapy of experimental endocarditis caused by multidrug-resistant Enterococcus faecium
1995
Failure of All Antifungal Therapy for Infection Due toCandida albicans. A New AIDS‐Related Problem?
1998
Reduction in the Incidence of Methicillin‐Resistant Staphylococcus aureus and Ceftazidime‐Resistant Klebsiella pneumoniae Following Changes in a Hospital Antibiotic Formulary
1999
Activity of Disinfectants Against Vancomycin-Resistant Enterococcus faecium
1997
Endemic Carbapenem-Resistant Acinetobacter Species in Brooklyn, New York: Citywide Prevalence, Interinstitutional Spread, and Relation to Antibiotic Usage
2000
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii Endemic in New York City
2003
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration
2012
Detection and Spread of Escherichia coli Possessing the Plasmid-Borne Carbapenemase KPC-2 in Brooklyn, New York
2007
Genetic relatedness of multidrug-resistantAcinetobacter baumanniiendemic to New York City
2008
Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae
2009
Citywide Clonal Outbreak of Multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY
2002
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
2010
Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 -Lactamases in New York City
2004
Experience with a hospital-wide outbreak of vancomycin-resistant enterococci
1996
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY
2007
Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City
2009
In vitro elution of ciprofloxacin from polymethylmethacrylate cement beads
1994
In vitro and in vivo activity of single and dual antimicrobial agents against KPC-producing Klebsiella pneumoniae
2017
Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns
2000
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents
2005
Rapid Spread of Carbapenem-Resistant Klebsiella pneumoniae in New York City
2005
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City
2010
Treatment of experimental endocarditis due to multidrug resistant Enterococcus faecium with ciprofloxacin and novobiocin
1994
Treatment of experimental endocarditis due to multidrug-resistant Enterococcus faecium with clinafloxzcin and penicillin
1996
Extrapulmonary Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1991
Emergence of KPC-Possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and Recommendations for Detection
2005
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium
1994
Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.
2002
Novel antibiotic regimens against Enterococcus faecium resistant to ampicillin, vancomycin, and gentamicin
1993
Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York
2005
Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci
1996
Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
2014
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
2009
Correlation of Antimicrobial Resistance with β-Lactamases, the OmpA-Like Porin, and Efflux Pumps in Clinical Isolates of Acinetobacter baumannii Endemic to New York City
2008
Accuracy of Carbapenem Nonsusceptibility for Identification of KPC-Possessing Enterobacteriaceae by Use of the Revised CLSI Breakpoints
2011
Activity of Disinfectants against Vancomycin-Resistant Enterococcus faecium
1997
Activity of clinafloxacin against multidrug-resistant Enterococcus faecium
1994
Irreproducible and Uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes
2013
Community-associated Methicillin-resistant Staphylococcus aureus in Hospital Nursery and Maternity Units
2005
Role of AmpD, OprF and penicillin-binding proteins in β-lactam resistance in clinical isolates of Pseudomonas aeruginosa
2007
Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City
2015
Interplay of Efflux System, ampC , and oprD Expression in Carbapenem Resistance of Pseudomonas aeruginosa Clinical Isolates
2006
Polymyxins Revisited
2008
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
2015
Evaluation of Techniques for Detection of Carbapenem-Resistant Klebsiella pneumoniae in Stool Surveillance Cultures
2005